HALO logo
halo search icon
X4 Pharmaceuticals, Inc.

US$3.77

Price Change Indicator
0.13 (3.57%)
X4 Pharmaceuticals, Inc.
XFOR · NAS

X4 Pharmaceuticals, Inc.

Start Trading XFOR for Free

US$3.77

Price Arrow0.13 (3.57%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueHALO Earnings MomentumHALO GrowthHALO Momentum+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

X4 Pharmaceuticals, Inc. Overview

XFOR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Weak

About XFOR

icon
icon

Telephone

1.857.529.8300

icon

Address

4th floor, 61 North Beacon Street, Boston, MA 02134

Description

X4 Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. It is focused on mavorixafor which is being marketed in the U.S. under the trade name xolremdi. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.

XFOR Price Chart

Key Stats

Market Cap

US$343.32M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.35 - 4.83

Trade Value (12mth)

US$1,131,922.00

1 week

-7.61%

1 month

-12.71%

YTD

-6.43%

1 year

31.41%

All time high

5164.97

Key Fundamentals

EPS 3 yr Growth

-95.90%

EBITDA Margin

-243.80%

Operating Cashflow

-$86m

Free Cash Flow Return

-47.40%

ROIC

-43.80%

Interest Coverage

-9.60

Quick Ratio

10.00

Other Data

Shares Outstanding (Fully Diluted)

126m

HALO Sector

Healthcare

Next Company Report Date

23-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

XFOR Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
13 May 26
13 May 26
06 May 26

XFOR Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-17.07-5.59-1.87locklocklock
EPS (Fully Diluted)
 $locklocklocklock-17.07-5.59-1.87locklocklock
Growth
 %locklocklocklock62.567.366.5locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of X4 Pharmaceuticals, Inc. (XFOR:NAS)?
Halo FAQ
The current share price of X4 Pharmaceuticals, Inc. (XFOR:NAS) is USD$3.77.
What is the 52-week high share price for X4 Pharmaceuticals, Inc. (XFOR:NAS)?
Halo FAQ
The 52-week high share price for X4 Pharmaceuticals, Inc. (XFOR:NAS) is USD$4.83.
What is the 52-week low share price for X4 Pharmaceuticals, Inc. (XFOR:NAS)?
Halo FAQ
The 52-week low share price for X4 Pharmaceuticals, Inc. (XFOR:NAS) is USD$1.35.
What is the dividend yield for X4 Pharmaceuticals, Inc. (XFOR:NAS)?
Halo FAQ
X4 Pharmaceuticals, Inc. (XFOR:NAS) does not pay a dividend.
What was X4 Pharmaceuticals, Inc. (XFOR:NAS) last dividend payment?
Halo FAQ
X4 Pharmaceuticals, Inc. (XFOR:NAS) does not pay a dividend.
What is the franking level for X4 Pharmaceuticals, Inc. (XFOR:NAS)?
Halo FAQ
X4 Pharmaceuticals, Inc. (XFOR:NAS) has a franking level of 0.00%.
In which sector is X4 Pharmaceuticals, Inc. (XFOR:NAS) classified?
Halo FAQ
X4 Pharmaceuticals, Inc. (XFOR:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial